Singapore markets closed

GeneDx Holdings Corp. (WGS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.60+0.88 (+4.46%)
At close: 04:00PM EDT
20.60 0.00 (0.00%)
After hours: 05:35PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close19.72
Open19.87
Bid20.46 x 100
Ask20.63 x 200
Day's range19.49 - 20.83
52-week range1.16 - 24.40
Volume381,871
Avg. volume430,179
Market cap538.709M
Beta (5Y monthly)2.26
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    GeneDx to Participate in Upcoming Investor Conferences

    STAMFORD, Conn., May 22, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in two upcoming investor conferences in June: Jefferies Healthcare Conference - New York City, New York Fireside chat on Wednesday, June 5 at 9:00 a.m. ET44th Annual Goldman Sachs Global Healthcare Conference - Miami, Florida Fireside chat on Monday, June 10 at 3:20 p.m. ET Live and archived webc

  • GlobeNewswire

    GeneDx Reports First Quarter 2024 Financial Results and Business Highlights

    Reported first quarter 2024 revenue from continuing operations1 of $61.5M with 96% year-over-year growth of exome and genome test revenue Expanded first quarter 2024 adjusted gross margins2 from continuing operations to 61% Narrowed first quarter 2024 adjusted net loss2 to $8.5M and delivered 71% year-over-year cash burn reduction Raised guidance to deliver between $235M and $245M in FY 2024 revenue and reiterate path to profitability in 2025 GeneDx to host conference call today at 4:30 p.m. ET

  • GlobeNewswire

    GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

    The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicineSTAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with Komodo Health, a premier healthcare technology company for the pharmaceutical industry. The new partnership will increase access to GeneDx's extens